DrugInformer Search

Chloroquine Phosphate; Primaquine Phosphate

Popular Brands: : Aralen Phosphate W/ Primaquine Phosphate, Chloroquine Phosphate; Primaquine Phosphate
Official FDA Reports0
Social Media Events0
Total Posts14
Avg. Review Score0.00/ 5
Active Ingredients
  • Chloroquine Phosphate; Primaquine Phosphate
Approved Uses *
  • No other uses available

* Extracted from Drug Label

Manufacturers
  • Sanofi Aventis Us Llc

  This report is for all products sharing this active ingredient. For more details, please use our Workbench for research on individual brands like Aralen Phosphate W/ Primaquine Phosphate.

* Extracted from FDA Adverse Event Report

Explanation

The quarterly trend chart illustrates changing levels of adverse events over time. Results from both the FDA Adverse Event Database (FAERS) and adverse events extracted from social media by Druginformer are plotted side-by-side for easy comparison.


The proportion of people completing user reviews who complained about a side effect.

The proportion of social media adverse event complaints for each adverse event type.

The proportion of FAERS (FDA) adverse event complaints for each adverse event type.


Chloroquine Phosphate; Primaquine Phosphate Side Effects

  Social Media
(Online Comments)
FAERS
(Reports Submitted to FDA)
Side Effect On Drug
Label
Overall
Alarm
Reports % of
Reports
Alarm Reports % of
Reports
Alarm

* DrugInformer calculates alarm using a proprietary algorithm. Alarm should not be taken as an ofiicial signal from the FDA or other regulatory entity.


User Voices

The following are comments from users that experienced side effects while taking Chloroquine Phosphate; Primaquine Phosphate

We do not have any user comments on this drug. Please try again with another drug.


Tell us about your Experience with Chloroquine Phosphate; Primaquine Phosphate

Thank you for sharing your experience with us!

Share Your Experience

Druginformer Identified Side Effects: None

Posted By UHS2012 in facebook.com on April 12, 2015 @ 12:00 am

April 12 at 8:48am · IMp PHARMACOLOGY MCQS with Answers 1.Which one of the following drugs increases gastrointestinal motility? a. Glycopyrrolate b. Atropine c. Neostigmine d. Fentanyl Correc...

Druginformer Identified Side Effects: None

Posted By Bettyg in mdjunction.com on December 16, 2014 @ 12:00 am

Insecticide Sprays Don't Offer Extra Protection Against Malaria: StudyInfection rates among kids in Africa were no better than when using bed nets aloneBy Robert PreidtTUESDAY, Dec. 9, 2014 (HealthDay...

Druginformer Identified Side Effects: None

Posted By Bettyg in mdjunction.com on November 3, 2014 @ 12:00 am

his link is from alex/evil....; haven't viewed this 53 min. videohttp:// www.alldocumentaries.org/ malaria-serial-killer/bg

Druginformer Identified Side Effects: None

Posted By Anonymous in facebook.com on September 19, 2014 @ 12:00 am

September 19, 2014 · Medications Used in Avian and Exotic Medicine Acetylsalicylic Acid (Aspirin): potent anti-inflammatory, useful for musculoskeletal pain, also will bring fever down; Acyclovir...

Druginformer Identified Side Effects: None

Posted By Bettyg in mdjunction.com on August 12, 2014 @ 12:00 am

Year-round preventive treatment reduces malaria risk in young childrenNIH-funded study shows benefit of monthly treatmentTuesday, August 5, 2014, 2 p.m. EDTA year-round preventive drug treatment subst...

Druginformer Identified Side Effects: None

Posted By Bettyg in mdjunction.com on August 6, 2014 @ 12:00 am

Pill-a-Month Hinders Malaria in KidsPublished: Aug 5, 2014By Michael Smith, North American Correspondent, MedPage Todaysave|AAA monthly pill appears to protect infants against malaria in regions where...

Druginformer Identified Side Effects: None

Posted By Bettyg in mdjunction.com on August 5, 2014 @ 12:00 am

Malaria Growing Resistant to Drugs Used to Fight ItBut several new drugs are in the development pipeline, experts sayWEDNESDAY, July 30, 2014 (HealthDay News) -- The parasite that causes malaria is gr...

Druginformer Identified Side Effects: None

Posted By Bettyg in mdjunction.com on June 10, 2014 @ 12:00 am

Malaria Treatment (United States)Treatment of Malaria: Guidelines For Clinicians (United States)Download PDF version of Parts 1-3 formatted for print Adobe PDF file [PDF, 79 KB, 8 pages]Part 1: Repor...

Druginformer Identified Side Effects: None

Posted By Bettyg in mdjunction.com on May 28, 2014 @ 12:00 am

Short-Term Malaria Reduction by Single-Dose Azithromycin during Mass Drug Administration for Trachoma, Tanzania Technical Appendix - 46 KB Adobe PDF fileSuggested CitationStephen E. Schachterle1, Geor...

Druginformer Identified Side Effects: None

Posted By Bettyg in mdjunction.com on May 27, 2014 @ 12:00 am

Approach shows promise in mice but more study needed before human trials can begin, experts say THURSDAY, May 22, 2014 (HealthDay News) -- Scientists have developed a new vaccine for malaria using pro...


Additional Drug Information


* Warning: The facts and figures contained in these reports are accurate to the best of our capability; however, our metrics are only meant to augment your medical knowledge, and should never be used as the sole basis for selecting a new medication. As with any medical decision, be sure to work with your doctor to ensure the best choices are made for your condition.

* About FAERS: The FDA Adverse Event Reporting System (FAERS) is used by FDA for activities such as looking for new safety concerns that might be related to a marketed product, evaluating a manufacturer's compliance to reporting regulations and responding to outside requests for information. Reporting of adverse events is a voluntary process, and not every report is sent to FDA and entered into FAERS. The FAERS database may contain duplicate reports, the report quality is variable, and many factors may influence reporting (e.g., media attention, length of time a drug is marketed, market share). For these reasons, FAERS case reports cannot be used to calculate incidence or estimates of risk for a particular product or compare risks between products.